EXCERPT

> The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, expressed serious concerns with Congress' recent proposal to amend Section 101 of the Patent Act. If enacted, the draft legislation would overturn 150 years of patent case law and permit patenting of human genes and naturally-occurring associations between genes and diseases. In a recent letter to Senators Coons and Tillis, and Representatives Collins, Johnson and Stivers, AMP joined a diverse community of 169 medical, scientific, patient advocacy, women's health, and civil rights organizations, opposing the recent proposal.

Source: https://www.amp.org/AMP/assets/File/pressreleases/2019/AMP_Section_101_Amendments_060419.pdf (PDF)

Letter: https://www.amp.org/AMP/assets/2019-06-03_Section_101_Legislation_Sign_On_Letter.pdf (PDF)